Cargando…

Cardiovascular Disease Related to Immune Therapy: JACC: CardioOncology Special Focus Issue

Detalles Bibliográficos
Autor principal:	Ky, Bonnie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Editor's Page
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830189/ https://www.ncbi.nlm.nih.gov/pubmed/36636450 http://dx.doi.org/10.1016/j.jaccao.2022.11.012

Ejemplares similares

JACC: CardioOncology: The Meaning of Family
por: Ky, Bonnie, et al.
Publicado: (2021)

JACC: CardioOncology: Serving and Advancing Our Cardiovascular and Oncology Communities
por: Ky, Bonnie
Publicado: (2020)

JACC: CardioOncology: Reflections on Tremendous Growth With Gratitude
por: Ky, Bonnie
Publicado: (2022)

JACC: CardioOncology: Poised to Serve a Maturing, Collaborative Field
por: Ky, Bonnie
Publicado: (2019)

Reflections on Our Inaugural Year of JACC: CardioOncology, With Gratitude and Tireless Devotion
por: Ky, Bonnie
Publicado: (2020)

JACC: CardioOncology 2022 Young Author Award Highlight
por: Ky, Bonnie
Publicado: (2023)

Cardiac Computed Tomography in Cardio-Oncology: JACC: CardioOncology Primer
por: Lopez-Mattei, Juan C., et al.
Publicado: (2021)

Cardiotoxicity of T-Cell Antineoplastic Therapies: JACC: CardioOncology Primer
por: Ganatra, Sarju, et al.
Publicado: (2022)

The ESC 2022 Cardio-Oncology Guidelines and the Road Ahead in Cardio-Oncology
por: Cheng, Richard K., et al.
Publicado: (2022)

My Hope for Cardio-Oncology
por: Ky, Bonnie
Publicado: (2022)

Cardiovascular Disease in Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review
por: Leiva, Orly, et al.
Publicado: (2022)

Cardiac Tumors: JACC CardioOncology State-of-the-Art Review
por: Tyebally, Sara, et al.
Publicado: (2020)

Resiliency and Our Cardio-Oncology Community
por: Ky, Bonnie
Publicado: (2020)

Cardio-Oncology and the Patient–Physician Relationship
por: Ky, Bonnie
Publicado: (2020)

How to Become a Cardio-Oncology Investigator
por: Ky, Bonnie
Publicado: (2021)

The Role of Cardioprotection in Cancer Therapy Cardiotoxicity: JACC: CardioOncology State-of-the-Art Review
por: Omland, Torbjørn, et al.
Publicado: (2022)

Considerations of Competing Risks Analysis in Cardio-Oncology Studies: JACC: CardioOncology State-of-the-Art Review
por: Li, Yimei, et al.
Publicado: (2022)

Developing a Clinical Cardio-Oncology Program and the Building Blocks for Success: JACC: CardioOncology How To
por: Fradley, Michael G., et al.
Publicado: (2023)

Electrophysiological Manifestations of Cardiac Amyloidosis: JACC: CardioOncology State-of-the-Art Review
por: Hartnett, Jack, et al.
Publicado: (2021)

Cardiometabolic Comorbidities in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review
por: Zullig, Leah L., et al.
Publicado: (2022)

Cancer Treatment-Related Cardiovascular Toxicity in Gynecologic Malignancies: JACC: CardioOncology State-of-the-Art Review
por: Parashar, Susmita, et al.
Publicado: (2023)

Magnetic Resonance Imaging to Detect Cardiovascular Effects of Cancer Therapy: JACC CardioOncology State-of-the-Art Review
por: Harries, Iwan, et al.
Publicado: (2020)

Immune Checkpoint Inhibitor Therapy in Oncology: Current Uses and Future Directions: JACC: CardioOncology State-of-the-Art Review
por: Tan, Sean, et al.
Publicado: (2022)

Cardiovascular Toxicities of BTK Inhibitors in Chronic Lymphocytic Leukemia: JACC: CardioOncology State-of-the-Art Review
por: Quartermaine, Cooper, et al.
Publicado: (2023)

AL Amyloidosis: Current Chemotherapy and Immune Therapy Treatment Strategies: JACC: CardioOncology State-of-the-Art Review
por: Bianchi, Giada, et al.
Publicado: (2021)

Atherosclerosis With Immune Checkpoint Inhibitor Therapy: Evidence, Diagnosis, and Management: JACC: CardioOncology State-of-the-Art Review
por: Suero-Abreu, Giselle Alexandra, et al.
Publicado: (2022)

The Evolving Immunotherapy Landscape and the Epidemiology, Diagnosis, and Management of Cardiotoxicity: JACC: CardioOncology Primer
por: Zhang, Lili, et al.
Publicado: (2021)

Genetics of Anthracycline Cardiomyopathy in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review
por: Bhatia, Smita
Publicado: (2020)

#JACCCardioOnc: Evolution of a Dedicated Social Media Strategy for JACC: CardioOncology
por: Brown, Sherry-Ann, et al.
Publicado: (2021)

Venous and Arterial Thromboembolism in Patients With Cancer: JACC: CardioOncology State-of-the-Art Review
por: Gervaso, Lorenzo, et al.
Publicado: (2021)

Cancer Immunotherapy Beyond Checkpoint Blockade: JACC: CardioOncology State-of-the-Art Review
por: Welty, Nathan E., et al.
Publicado: (2022)

Cardioprotection in Patients at High Risk of Anthracycline-Induced Cardiotoxicity: JACC: CardioOncology Primer
por: Henriksen, Peter A., et al.
Publicado: (2023)

Incorporating Exercise Training into Cardio-Oncology Care: Current Evidence and Opportunities: JACC: CardioOncology State-of-the-Art Review
por: Wilson, Rebekah L., et al.
Publicado: (2023)

Potential Applications for Targeted Gene Therapy to Protect Against Anthracycline Cardiotoxicity: JACC: CardioOncology Primer
por: Kok, Cindy Y., et al.
Publicado: (2021)

Mechanistic and Clinical Overview Cardiovascular Toxicity of BRAF and MEK Inhibitors: JACC: CardioOncology State-of-the-Art Review
por: Glen, Claire, et al.
Publicado: (2022)

Cardiovascular Toxicity of Proteasome Inhibitors: Underlying Mechanisms and Management Strategies: JACC: CardioOncology State-of-the-Art Review
por: Georgiopoulos, Georgios, et al.
Publicado: (2023)

ATTR Amyloidosis: Current and Emerging Management Strategies: JACC: CardioOncology State-of-the-Art Review
por: Griffin, Jan M., et al.
Publicado: (2021)

Screening for Coronary Artery Disease in Cancer Survivors: JACC: CardioOncology State-of-the-Art Review
por: Velusamy, Ragani, et al.
Publicado: (2023)

JACC Journals’ Pathway Forward With AI Tools: The Future Is Now
por: Fuster, Valentin, et al.
Publicado: (2023)

JACC Journals’ Pathway Forward With AI Tools: The Future Is Now
por: Fuster, Valentin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0teemrtnv51agfhdt7lf34pjm3